FIELD: pharmaceutical industry and technology, pharmacy.
SUBSTANCE: invention relates to a method for manufacturing a solid medicinal formulation - glucosamine hydrochloride tablets representing an anti-arthrosis preparation. Glucosamine hydrochloride, microcrystalline cellulose and average-molecular polyvinylpyrrolidone are placed in mixer followed by addition of talk and calcium stearate through a sieve in the process of stirring. Mixer is closed and stirring is continued and then mixture is tableted by the direct pressing method. Tablets are removed dust and dispensed. Invention provides making tablets by the improved technology wherein the labor-consuming granulation stage with using explosive reagent ethyl alcohol is excluded.
EFFECT: improved preparing method.
4 tbl, 3 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ROSUVASTATIN CALCIUM SALT (VERSIONS) | 2015 |
|
RU2606592C1 |
| SOLID DOSAGE FORM OF CLOPIDOGREL AND METHOD FOR PREPARING THEREOF | 2009 |
|
RU2393862C1 |
| DIOSMIN SOLID MEDICINAL FORMULATION | 2005 |
|
RU2314812C2 |
| MEDICINAL PREPARATION FOR TREATING CARDIOVASCULAR DISEASES | 2001 |
|
RU2203051C1 |
| SULFADIMEZINE-BASE ANTIBACTERIAL AGENT | 2003 |
|
RU2233154C1 |
| COMPLEX MEDICINAL AGENT IN TABLETED FORM FOR CORRECTION OF HIGH BLOOD VISCOSITY SYNDROME | 2017 |
|
RU2691936C1 |
| METHOD FOR PRODUCTION OF ANTIOXIDANT PREPARATION IN FORM OF TABLET | 2020 |
|
RU2749718C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING URINARY DISTURBANCES | 2012 |
|
RU2497504C1 |
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
